Eukaryotic translation initiation factor 3 subunit M (EIF3M)
Target
EIF3M
Molecular classification
Translation initiation factor (subunit of eIF3 complex), PCI domain-containing protein, Other (since it is neither a classical receptor, enzyme, transporter, nor channel, but is a multi-subunit regulatory factor in protein synthesis)
01
Overview
Eukaryotic translation initiation factor 3 subunit M (EIF3M) is an essential component of the eIF3 multi-protein complex, which is required for initiation of protein synthesis in eukaryotic cells. EIF3M contains a PCI domain and helps define distinct subpopulations of the eIF3 complex, allowing selective binding and translation of specific mRNAs, particularly those involved in cell proliferation, apoptosis, and differentiation. It is vital for recruitment of translation initiation factors and ribosomal subunits, and its function impacts cellular protein homeostasis and quality control. Alterations or dysfunctions in EIF3M and the eIF3 complex are associated with diseases such as cancer and viral infections, making EIF3M a candidate therapeutic target, though it is not yet clinically drugged.
Other names
EIF3MeIF3mHFLB5PCID1GA17PNAS-125hFL-B5FLJ29030TANGO7Fetal lung protein B5PCI domain-containing protein 1transport and golgi organization 7 homolog (Drosophila)dendritic cell protein
02
Mechanism of action
Inhibition of protein synthesis initiation (downregulation of eIF3 function)
Disruption of mRNA recruitment and ribosome assembly (theoretical/mechanistic studies)
03
Biological functions
Initiation of protein synthesismRNA recruitment and scanningRegulation of translation initiation (selection of mRNAs for translation)Cell proliferation, cycling, differentiation, and apoptosis (by controlling translation of subset of mRNAs)Disassembly/recycling of post-termination ribosomal complexesPrevention of premature ribosomal subunit joiningQuality control in protein productionProtein homeostasis and folding
04
Disease associations
Cancer (implicated in tumor progression)ApoptosisInfection (herpes simplex virus)Potential roles in neurodegenerative and other diseases via general translation control mechanismsOther: possible involvement in cystic fibrosis (via translational control of CFTR protein)
05
Safety considerations
Therapeutic targeting of EIF3M or the eIF3 complex could disrupt global protein synthesis, potentially causing cytotoxicity, impaired cell viability, and off-target effectsBroad inhibition could interfere with protein homeostasis and normal cell function
06
Interacting drugs
No directly approved drugs currently target EIF3M specifically; however, eIF3 complex and subunits have been explored as potential targets in anti-cancer strategies
2 more in the full profile.
07
Biomarkers
No widely validated biomarkers for patient selection or monitoring specifically related to EIF3MeIF3 subunit levels and mutations may be explored as future translational dysfunction markers in cancer or infection
Beyond the preview
Go deeper on Eukaryotic translation initiation factor 3 subunit M (EIF3M).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Full profile access
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Full profile access
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Full profile access
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Full profile access
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Full profile access
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Full profile access
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eukaryotic translation initiation factor 3 subunit M (EIF3M).